Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Raw Materials (2023 - 2025)

SRx Health Solutions' Raw Materials history spans 3 years, with the latest figure at $542000.0 for Q3 2025.

  • For Q3 2025, Raw Materials fell 31.22% year-over-year to $542000.0; the TTM value through Sep 2025 reached $542000.0, down 31.22%, while the annual FY2025 figure was $542000.0, N/A changed from the prior year.
  • Raw Materials reached $542000.0 in Q3 2025 per SRXH's latest filing, down from $550000.0 in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $1.1 million in Q4 2023 to a low of $542000.0 in Q3 2025.
  • Average Raw Materials over 3 years is $749666.7, with a median of $752500.0 recorded in 2024.
  • Peak YoY movement for Raw Materials: plummeted 31.27% in 2024, then crashed 31.22% in 2025.
  • A 3-year view of Raw Materials shows it stood at $1.1 million in 2023, then tumbled by 31.27% to $765000.0 in 2024, then fell by 29.15% to $542000.0 in 2025.
  • Per Business Quant, the three most recent readings for SRXH's Raw Materials are $542000.0 (Q3 2025), $550000.0 (Q2 2025), and $740000.0 (Q1 2025).